Session 2 summary

This session has focused on identifying changes in the brain that occur with ADHD, and how these might impact on cognition and behaviour. In particular the role of the neurotransmitter dopamine has been highlighted because the ‘dopamine theory of ADHD’ has been a key part of ADHD research, despite the fact that it has also been questioned (you learnt about Gonon’s criticisms from 2009). In addition, the session has also explained how ADHD medication may be affecting the brain, comparing these forms of symptom relief to other forms of ADHD management.